HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ischemic optic neuropathy decompression trial (IONDT): design and methods.

Abstract
The objective of the Ischemic Optic Neuropathy Decompression Trial (IONDT) was to investigate the safety and efficacy of optic nerve decompression surgery (ONDS) compared to careful follow-up for nonarteritic ischemic optic neuropathy (NAION) and to observe the natural history of NAION in untreated patients. It was designed as a multicenter, randomized controlled clinical trial. Resource centers included a Chairman's Office, a Coordinating Center, and 25 Clinical Centers at eye centers throughout the United States. The trial's methods were as follows. Eligible patients with visual acuity 20/64 or worse were randomized to ONDS or careful follow-up; eligible patients with visual acuity better than 20/64 made up a natural history cohort and were followed but not randomized to treatment. The primary outcome examined was an increase of three lines or more of visual acuity at 6 months. Additional outcomes were visual acuity at other follow-up times, visual field, quality of life, and morbidity associated with ONDS. Standard quality assurance methodology was used to monitor adherence to protocol. The surgical protocol was monitored by a Surgical Quality Assurance Committee (SQAC). Enrollment began October 8, 1992, and ceased October 20, 1994, because of preliminary findings indicating that surgery was of no benefit and was perhaps harmful. This report describes the design and methods of the trial and the rationale for design elements unique to the IONDT. Specific goals of study design and conduct included achieving an accelerated study start-up and rapidly producing results acceptable to the medical community.
Authors
JournalControlled clinical trials (Control Clin Trials) Vol. 19 Issue 3 Pg. 276-96 (Jun 1998) ISSN: 0197-2456 [Print] United States
PMID9620811 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Data Interpretation, Statistical
  • Humans
  • Middle Aged
  • Multicenter Studies as Topic
  • Optic Neuropathy, Ischemic (surgery)
  • Outcome Assessment, Health Care (methods)
  • Patient Selection
  • Quality of Life
  • Randomized Controlled Trials as Topic (methods)
  • Research Design
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: